Recipient Study Drug definition

Recipient Study Drug means the Recipient’s proprietary oncolytic virus known as RP-1.
Sample 1Sample 2Sample 3
Recipient Study Drug means the Recipient’s TLR-9 Agonist (Toll-Like Receptor Agonist), IMO-2125.
Sample 1Sample 2Sample 3
Recipient Study Drug means the Recipient’s proprietary sitravatinib compound, including salts thereof and any drug candidate or product containing such compound.
Sample 1Sample 2

Examples of Recipient Study Drug in a sentence

  • The Recipient Study Drug shall be manufactured in accordance with Applicable Law (including GMP) and shall be of similar quality to the Recipient Study Drug used by the Recipient for its other clinical trials of the Recipient Study Drug.

  • Usual Nutrient Intake from Food and Beverages, among Non-Hispanic Asian Individuals, What We Eat in America, NHANES 2015-2018.

  • BW Equities Limited has not authorised or caused the issue of, and expressly disclaims and takes no responsibility for, any part of the Prospectus.

  • In all cases, the specific Classes that have been aggregated shall be mentioned in conjunction with the classified quantity (e.g. 111+112+221+222) and a footnote added.

  • As it relates to disclosures involving the BMS Study Drug, the Recipient Study Drug or the conduct of the Combined Therapy Clinical Trial only, the CDA is hereby terminated and replaced by the terms of this Agreement.

  • During the Term, each of the Parties agrees to discuss in good faith, for a period of no longer than [ ]*, additional Combined Therapy Clinical Trials of the BMS Study Drug with the Recipient Study Drug (and/or follow-on versions of the Recipient Study Drug).

  • It is not possible using this data to robustly identify if the presence of either an on-slip or off slip for a motorway or trunk road would affect driver behaviour in and around the junction.

  • K dispozici je 30 indikátorů životního prostředí od EN1 (spotřeba materiálu, přes spotřebu energii, vody, biodiverzita, emise, odpady, produkty, služby až pod celkové výdaje na životní prostředí) až po EN30 (GRI, 2014).

  • As between BMS and Recipient, (a) BMS shall own the particular Study Data that relate exclusively to the BMS Study Drug (“BMS Study Data”), and the Recipient shall own the particular Study Data that relate exclusively to the Recipient Study Drug (“Recipient Study Data”), and (b) both Parties shall jointly own any and all Study Data that is not Recipient Study Data or the BMS Study Data (“Combined Therapy Study Data”).

  • BMS shall own the Study Data to the extent that it relates solely to the BMS Study Drug (“BMS Study Data”), and Recipient shall own the Study Data to the extent that it relates solely to the Recipient Study Drug (“Recipient Study Data”).


More Definitions of Recipient Study Drug

Recipient Study Drug means the Recipient’s proprietary small molecule vascular endothelial growth factor (“VEGF”) tyrosine kinase inhibitor (“TKI”) known as Fotivda® (tivozanib).
Sample 1Sample 2Sample 3

Related to Recipient Study Drug

  • Manufacturing site means the facilities where a Compound is Manufactured by or on behalf of a Party, as such Manufacturing Site may change from time to time in accordance with Section 8.7.

  • Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams, and other information furnished by the Contractor to illustrate materials or equipment for some portion of the Work.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Drug sample means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.